litlas
Log inCreate account

Juha Kononen

Active 1990–2025

46
Papers
18,421
Citations
40
h-index
46
i10-index

Citations

Citations per year for Juha Kononen1991: 2 citations1992: 3 citations1993: 7 citations1994: 4 citations1995: 5 citations1996: 13 citations1997: 20 citations1998: 78 citations1999: 111 citations2000: 168 citations2001: 348 citations2002: 424 citations2003: 456 citations2004: 519 citations2005: 378 citations2006: 308 citations2007: 287 citations2008: 255 citations2009: 237 citations2010: 205 citations2011: 180 citations2012: 132 citations2013: 106 citations2014: 104 citations2015: 93 citations2016: 64 citations2017: 49 citations2018: 44 citations2019: 178 citations2020: 184 citations2021: 155 citations2022: 119 citations2023: 63 citations2024: 92 citations2025: 42 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,292 citing papers, 34.1% of this breakdownUnited Kingdom: 486 citing papers, 7.2% of this breakdownGermany: 449 citing papers, 6.7% of this breakdownChina: 303 citing papers, 4.5% of this breakdownCanada: 295 citing papers, 4.4% of this breakdownSwitzerland: 242 citing papers, 3.6% of this breakdownItaly: 210 citing papers, 3.1% of this breakdownNetherlands: 207 citing papers, 3.1% of this breakdownFrance: 204 citing papers, 3% of this breakdownSweden: 180 citing papers, 2.7% of this breakdownFinland: 179 citing papers, 2.7% of this breakdownJapan: 168 citing papers, 2.5% of this breakdown
0%34.1%Other 22.4%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology52.5%
  • Medicine37.6%
  • Neuroscience2.5%
  • Computer Science2.3%
  • Immunology and Microbiology1.5%
  • Chemistry1%
  • Other2.6%

Topics

  • Gene expression and cancer classification4.4%
  • Estrogen and related hormone effects4.1%
  • Prostate Cancer Treatment and Research3.1%
  • HER2/EGFR in Cancer Research2.9%
  • Breast Cancer Treatment Studies2.5%
  • Cancer Cells and Metastasis1.9%
  • Other81.1%

Coauthors

All papers

Open in search
  1. Tissue microarrays for high-throughput molecular profiling of tumor specimens

    Authors: Juha Kononen, Lukas Bubendorf, Anne Kallionimeni, Maarit Bärlund, Peter Schraml, Stephen B. Leighton, J. Torhorst, Michael J. Mihatsch, Guido Sauter, Olli-P. Kallionimeni - Nature Medicine 1998 cited by 4,135

  2. A Deep Learning-Based Automated CT Segmentation of Prostate Cancer Anatomy for Radiation Therapy Planning-A Retrospective Multicenter Study

    Authors: Timo Kiljunen, Saad Ullah Akram, Jarkko Niemelä, Eliisa Löyttyniemi, Jan Seppälä, Janne Heikkilä, Kristiina Vuolukka, Okko‐Sakari Kääriäinen, Vesa-Pekka Heikkilä, Kaisa Lehtiö, Juha Nikkinen, E. Gershkevitsh, Anni Borkvel, M. Adamson, D. Zolotuhhin, K. Kolk, Eric Pei Ping Pang, Jeffrey Tuan, Zubin Master, Melvin L.K. Chua, Timo Joensuu, Juha Kononen, Mikko Myllykangas, Maigo Riener, Miia Mokka, Jani Keyriläinen - Diagnostics 2020 cited by 74

  3. Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study

    Authors: Pia Österlund, Tapio Salminen, Leena-Maija Soveri, Raija Kallio, Ilmo Kellokumpu, Annamarja Lamminmäki, Päivi Halonen, Raija Ristamäki, Eila Lantto, Aki Uutela, Emerik Österlund, Ali Ovissi, Arno Nordin, Eetu Heervä, Kaisa Lehtomäki, Jari Räsänen, M. Murashev, Laura Aroviita, Antti Jekunen, Reneé Lindvall-Andersson, Paul Nyandoto, Juha Kononen, Anna Lepistö, Tuija Poussa, Timo Muhonen, Annika Ålgars, Helena Isoniemi - The Lancet Regional Health - Europe 2021 cited by 108

  4. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers

    Authors: Philip Went, Mohammad Vasei, Lukas Bubendorf, Luigi Terracciano, Luigi Tornillo, Ursus-Nikolaus Riede, Juha Kononen, Ronald Simon, Guido Sauter, Patrick A. Baeuerle - British Journal of Cancer 2006 cited by 384

  5. Gene-Expression Profiles in Hereditary Breast Cancer

    Authors: Ingrid Hedenfalk, David Duggan, Yidong Chen, Michael D. Radmacher, Michael Bittner, Richard H. Simon, Paul S. Meltzer, B.A. Gusterson, Manel Esteller, Mark Raffeld, Zohar Yakhini, Amir Ben-Dor, Edward Dougherty, Juha Kononen, Lukas Bubendorf, Wilfrid Fehrle, Stefania Pittaluga, Sofia Gruvberger, Niklas Loman, Oskar Johannsson, Håkan Olsson, Benjamin Wilfond, Guido Sauter, Olli-P. Kallioniemi, Åke Borg, Jeffrey Trent - New England Journal of Medicine 2001 cited by 1,744

  6. AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer

    Authors: Sarah L. Anzick, Juha Kononen, Robert L. Walker, David O. Azorsa, Minna M. Tanner, Xin‐Yuan Guan, Guido Sauter, Olli Kallioniemi, Jeffrey M. Trent, Paul S. Meltzer - Science 1997 cited by 1,661

  7. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.

    Authors: Cai Bowen, Lukas Bubendorf, Heinz Voeller, Rebecca Slack, Niels Willi, G Sauter, Thomas C. Gasser, Pasi Koivisto, Ernest E. Lack, Juha Kononen, Olli Kallioniemi, Edward P. Gelmann - 2000 cited by 383

  8. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.

    Authors: Pasi A. Koivisto, Juha Kononen, Christian Palmberg, Teuvo L.J. Tammela, E. Hyytinen, Jorma Isola, Jan Trapman, Kitty B.J.M. Cleutjens, Marinus A. Noordzij, Tapio Visakorpi, Olli Kallioniemi - 1997 cited by 725

  9. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

    Authors: Leendert H. J. Looijenga, Hans Stoop, Hubert P. J. C. de Leeuw, Carlos A. de Gouveia Brazao, Ad Gillis, Kees E. P. van Roozendaal, E.J.J. van Zoelen, Rob F.A. Weber, Katja P. Wolffenbuttel, Herman van Dekken, Friedemann Honecker, Carsten Bokemeyer, Elizabeth J. Perlman, Dominik T. Schneider, Juha Kononen, Guido Sauter, J. Wolter Oosterhuis - 2003 cited by 646

  10. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

    Authors: Lukas Bubendorf, Juha Kononen, Pasi A. Koivisto, Peter Schraml, Holger Moch, Thomas C. Gasser, Niels Willi, M. J. Mihatsch, G Sauter, Olli Kallioniemi - 1999 cited by 602

  11. A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer

    Authors: Pia Vahteristo, Jiřina Bártková, Hannaleena Eerola, Kirsi Syrjäkoski, Salla Ojala, Outi Kilpivaara, Anitta Tamminen, Juha Kononen, Kristiina Aittomäki, Päivi Heikkilä, Kaija Holli, Carl Blomqvist, Jiří Bártek, Olli Kallioniemi, Heli Nevanlinna - The American Journal of Human Genetics 2002 cited by 477

  12. The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial

    Authors: Matthew S. Block, James H.A. Clubb, Johanna Mäenpää, Santeri A. Pakola, Dafne C.A. Quixabeira, Tatiana V. Kudling, Elise Jirovec, Lyna Haybout, Mirte van der Heijden, Sanae Zahraoui, Susanna Grönberg-Vähä-Koskela, Sini Raatikainen, Victor Arias, Saru Basnet, Nea Ojala, Teijo Pellinen, Annabrita Hemmes, Katja Välimäki, Annukka Pasanen, Tuomo Alanko, Daniel A. Adamo, Susan Ramadan, Jorma Sormunen, Juha Kononen, Julia W. Cohen, Michael Chisamore, John Goldfinch, Suvi Sorsa, Riikka Havunen, Claudia Kistler, Aino Kalervo, Víctor Cervera-Carrascón, João M. Santos, Akseli Hemminki - Nature Communications 2025 cited by 29

  13. Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome

    Authors: Matt van de Rijn, Charles M. Perou, Rob Tibshirani, Phillippe Haas, Olli Kallioniemi, Juha Kononen, J. Torhorst, Guido Sauter, Markus Zuber, Ossi R. Köchli, Frank Mross, Holger Dieterich, Rob Seitz, D. T. Ross, David Botstein, Pat Brown - American Journal Of Pathology 2002 cited by 564

  14. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.

    Authors: Tuula Kuukasjärvi, Juha Kononen, Heikki Helin, K Holli, Jorma Isola - Journal of Clinical Oncology 1996 cited by 358

  15. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays.

    Authors: Spyro Mousses, Lukas Bubendorf, Urs Wagner, Galen Hostetter, Juha Kononen, Robert Cornelison, Natalie Goldberger, Abdel Elkahloun, Niels Willi, Pasi A. Koivisto, William Ferhle, Mark Raffeld, G Sauter, Olli Kallioniemi - 2002 cited by 167

  16. Impaired Expression of the Cell Cycle Regulator BTG2 Is Common in Clear Cell Renal Cell Carcinoma

    Authors: Kirsten Struckmann, Peter Schraml, Ronald Simon, Katja Elmenhorst, Martina Mirlacher, Juha Kononen, Holger Moch - Cancer Research 2004 cited by 98

  17. Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study

    Authors: Aki Uutela, Emerik Österlund, Päivi Halonen, Raija Kallio, Annika Ålgars, Tapio Salminen, Annamarja Lamminmäki, Leena‐Maija Soveri, Raija Ristamäki, Kaisa Lehtomäki, Hanna Stedt, Eetu Heervä, Timo Muhonen, Juha Kononen, Arno Nordin, Ali Ovissi, Soili Kytölä, Mauri Keinänen, Jari Sundström, Lasse Nieminen, Markus J. Mäkinen, Teijo Kuopio, Ari Ristimäki, Helena Isoniemi, Pia Österlund - British Journal of Cancer 2022 cited by 18

  18. Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical Endpoints

    Authors: J. Torhorst, Christoph Bucher, Juha Kononen, Philippe Haas, Markus Zuber, Ossi R. Köchli, Frank Mross, Holger Dieterich, Holger Moch, Michael J. Mihatsch, Olli Kallioniemi, Guido Sauter - American Journal Of Pathology 2001 cited by 569

  19. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer.

    Authors: Maarit Bärlund, Outi Monni, Juha Kononen, Robert Cornelison, J. Torhorst, Guido Sauter, Kallioniemi OLLI-P, Anne Kallioniemi - 2000 cited by 199

  20. Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation.

    Authors: Helena E. Miettinen, Juha Kononen, Hannu Haapasalo, Pauli Helén, P Sallinen, T Harjuntausta, Heikki Helin, Hannu Alho - 1995 cited by 176

  21. Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

    Authors: Petros Grivas, Elena Garralda, Funda Meric‐Bernstam, Ingo K. Mellinghoff, Lipika Goyal, James J. Harding, Elizabeth Claire Dees, Rastislav Bahleda, Nilofer S. Azad, Asha Karippot, Razelle Kurzrock, Josep Tabernero, Juha Kononen, Matthew Chau Hsien Ng, Rutika Mehta, Nataliya V. Uboha, Frédéric Bigot, Valentina Boni, Samantha E. Bowyer, В. В. Бредер, Andrés Cervantes, Nancy Chan, James M. Cleary, Mallika Dhawan, Rikke Løvendahl Eefsen, James Ewing, Donna M. Graham, Tormod Kyrre Guren, Jin Won Kim, Krassimir Koynov, Do‐Youn Oh, Rebecca Redman, Chia‐Jui Yen, David Spetzler, Marie-Claude Roubaudi-Fraschini, Valerie Nicolas-Metral, Rafik Ait-Sarkouh, Claudio Zanna, Abdallah Ennaji, Anna Pokorska-Bocci, Keith T. Flaherty - Clinical Cancer Research 2024 cited by 12

  22. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.

    Authors: S L Sallinen, P Sallinen, Hannu Haapasalo, Heikki J. Helin, Pauli Helén, Peter Schraml, Olli Kallioniemi, Juha Kononen - 2000 cited by 333

  23. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

    Authors: Antonio Nocito, Lukas Bubendorf, Eva Maria Tinner, Katrin Süess, Urs Wagner, T. Förster, Juha Kononen, André Fijan, James Bruderer, U Schmid, Daniel Ackermann, Robert Maurer, Göran Alund, H Knönagel, Marcus Rist, M Anabitarte, Franz Hering, Thomas Hardmeier, Andreas J. Schoenenberger, Renata Flury, Peter Jäger, Jean Luc Fehr, Peter Schraml, Holger Moch, Michael J. Mihatsch, Thomas Gasser, Guido Sauter - The Journal of Pathology 2001 cited by 322

  24. Patterns of HER-2/neu Amplification and Overexpression in Primary and Metastatic Breast Cancer

    Authors: Ronald Simon, Antonio Nocito, T. Hubscher, Christoph Bucher, J Torhorst, Peter Schraml, Lukas Bubendorf, M Mihatsch, H. Moch, Kim Wilber, Andreas Schötzau, Juha Kononen, Guido Sauter - JNCI Journal of the National Cancer Institute 2001 cited by 292